Skip to main content

Table 2 Univariate analysis of factors associated with OS

From: Comparison of survival outcomes of locally advanced cervical cancer by histopathological types in the surveillance, epidemiology, and end results (SEER) database: a propensity score matching study

VariablesUnivariate (OS) 
HR (95%CI)P value
histology
 AC1.00 (reference) 
 SCC1.02 (0.93–1.12)0.69
age (%)
  < 401.00 (reference) 
 40–491.03 (0.93–1.13)0.61
 50–590.97 (0.88–1.08)0.59
 60–691.01 (0.90–1.14)0.81
race (%)
 Black1.00 (reference) 
 White1.06 (0.95–1.18)0.28
 Other1.20 (1.03–1.39)0.02
grade (%)
 I1.00 (reference) 
 II1.07 (0.93–1.24)0.36
 III1.00 (0.86–1.15)0.95
 IV1.12 (0.82–1.53)0.47
FIGO stage (%)
 Ib21.00 (reference) 
 IIa11.02 (0.81–1.27)0.88
 IIa21.17 (0.96–1.43)0.12
 IIb0.98 (0.87–1.10)0.72
 IIIa1.07 (0.80–1.42)0.64
 IIIb1.00 (0.90–1.11)0.94
 IVa0.74 (0.57–0.98)0.03
sequence (%)
 No surgery1.00 (reference) 
 RPTS0.88 (0.73–1.05)0.16
 RAS0.93 (0.87–1.01)0.10
 RBAS1.11 (0.72–1.73)0.63
Radiation (%)
 Beam radiation1.00 (reference) 
 brachytherapy0.98 (0.86–1.11)0.70
 BRB0.93 (0.86–1.00)0.06
Chemotherapy
 Yes1.00 (reference) 
 No0.85 (0.75–0.97)0.01
  1. AC adenocarcinoma, SCC Squamous cell carcinoma, FIGO the International Federation of Gynecology and Obstetrics, RPTS Radiation prior to surgery, RAS Radiation after surgery, RBAS Radiation before and after surgery, BRB Combination of beam with brachytherapy, grade I Well differentiated,gradeII Moderately differentiated,gradeIII Poorly differentiated,gradeIV Undifferentiated;CI indicates confidence interval, HR hazard ratio